The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome
Qiang Gao(Northeastern University), Yuming Liu(Fudan University), Jiaqiang Ma(Ministry of Education), Lingyu Tian(Universität Hamburg), Xiaoming Zhang(Chinese Academy of Sciences), Guohe Song(Fudan University), Xiaoying Wang(Xidian University), Jia Fan(Nanjing Tech University), Jian Zhou(Ministry of Education of the People's Republic of China), Shuaixi Yang(Fudan University), Jie-Yi Shi(Fudan University), Liangqing Dong(Fudan University), Jiao‐Men Pan(Fudan University)
Cited by 41
Related Papers
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
|Liver Cancer|2020|828